FIELD: medicine.
SUBSTANCE: polymorphism of the AGTR2 rs1403543 gene is determined. In case of detection of a homozygous version of GG, perindopril dose is 1.3 times lower than in individuals with allele version AA.
EFFECT: increased therapy effectiveness and safety.
4 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING THE RISK OF THROMBOTIC COMPLICATIONS OF PATIENTS WITH CARDIOVASCULAR PATHOLOGY | 2020 |
|
RU2746234C1 |
METHOD OF SELECTING TREATMENT TACTICS FOR PATIENTS WITH ANTIPSYCHOTIC-INDUCED EXTRAPYRAMIDAL DISORDERS | 2022 |
|
RU2810798C1 |
METHOD FOR PREDICTING RISK OF DEVELOPMENT OF ISCHEMIC HEART DISEASE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2620545C1 |
METHOD FOR DIFFERENTIATED CHOICE OF PHARMACOTHERAPY OF ARTERIAL HYPERTENSION WITH UNDERLYING DORSOPATHY IN OPERATORS | 2024 |
|
RU2826094C1 |
METHOD FOR CHOOSING THE STARTING SCHEME OF POSTOPERATIVE ANESTHESIA IN PATIENTS AFTER VIDEOLAPAROSCOPIC CHOLECYSTECTOMY | 2021 |
|
RU2779003C1 |
METHOD FOR IMPROVING DRUG USE SAFETY IN TREATING PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME | 2018 |
|
RU2690522C1 |
METHOD FOR DETECTION OF GENETIC PREDISPOSITION TO DEVELOPING MYOCARIAL INFARCTION IN INDIVIDUALS WITH NO CLINICAL IMPLICATIONS OF ISCHEMIC HEART DISEASE | 2011 |
|
RU2469096C2 |
METHOD FOR PREDICTING THE DEGREE OF RISK OF EXTRAPYRAMID SIDE EFFECTS DURING THE BACKGROUND OF HALOPERIDOL THERAPY IN PATIENTS WITH SCHIZOPHRENIC SPECTRUM DISORDERS | 2021 |
|
RU2771180C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING COMPLICATIONS IN PATIENTS WITH ISCHEMIC HEART DISEASE ASSOCIATED WITH DIABETES TYPE 2 | 2015 |
|
RU2578449C1 |
METHOD FOR PREDICTING DEVELOPMENT OF LEFT ATRIAL DILATATION IN PATIENTS WITH DISORDERS OF HEART RHYTHM | 2018 |
|
RU2680148C1 |
Authors
Dates
2018-01-24—Published
2016-11-07—Filed